Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Repurposing Drugs for CMT1A: An Encouraging Approach
…project underscores CMTA’s commitment to supporting cutting-edge research and fostering collaboration between the CMT community, clinicians, and industry experts. CMTA’s Strategy To Accelerate Research (STAR) initiatives continue to be vital…
CMTA’s $300K Investment in CRISPR for CMT2A
The Charcot-Marie-Tooth Association (CMTA) is investing $300,000 in a groundbreaking gene editing research project at Gladstone Institutes to develop a CRISPR-based therapy for CMT2A. This CMTA Strategy To Accelerate Research…
CMTA Board of Directors
…managers, doctors, lawyers, or public servants, they have the expertise to oversee the organization’s operations and formulate its strategy for funding research and finding a cure. As individuals, whether they…
MDA and CMTA Fund Grant to Study Gene Therapy in Charcot-Marie-Tooth Disease
…core of the CMTA’s STAR (Strategy to Accelerate Research) approach to finding treatments for various types of CMT, so we are very pleased to announce today the first research project…
Toxic Medications List For Patients with Charcot-Marie-Tooth Disease
…shaping and delivering the CMTA’s research strategies. The CMTA currently has more than 50 active research projects, including sponsored research grants with academic labs and pre-clinical testing studies with biotech/pharma…
What is CMTA-STAR?
…poised to become reality as CMTA-STAR pushes the Charcot-Marie-Tooth research forward at an ever-increasing speed. One of the first ways that CMTA accelerates CMT research is by capitalizing on advances…
CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants
An international team of researchers from the Inherited Neuropathies Consortium (INC), led by CMTA’s Strategy To Accelerate Research (CMTA-STAR) Advisory Board Member Michael Shy, MD, at the University of Iowa,…